Check out all the latest news from SENS Research Foundation in our June newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

Immusoft founder and CTO Matthew Scholz discussed the company's "ISP" platform technology, which uses a patient's own immune cells to produce therapeutic proteins on a long-term basis - enabling cures for many genetic and age-related diseases.

The Life Extension Advocacy Foundation (LEAF) are hosting a special one-day conference in New York on July 12th. Key researchers, industry experts and investors will meet to discuss how rejuvenation biotechnology can be translated into the clinic.

UCLA human genetics professor Steve Horvath, who developed the "Horvath clock" - a highly accurate molecular biomarker of aging - spoke at Undoing Aging 2018 about the use of epigenetics to measure the benefits of rejuvenation therapies.

The Britain Israel Research and Academic Exchange Partnership (BIRAX) has issued a call for research proposals focused on directly tackling the aging process to prevent age-related disease. We applaud the UK and Israeli governments for their very SENSible approach!

Dr. John Lewis, Chief Science Officer of Oisín Biotechnologies - which counts SRF as a founding investor - spoke at Undoing Aging 2018 about the latest progress in the company's efforts to develop safe and highly selective senolytic drugs.

Our next Undoing Aging 2018 video features Dr. Mike West, founder and CEO of AgeX Therapeutics, who presented their work on induced tissue regeneration - leveraging the unique regenerative potential of pluripotent stem-cell-derived therapeutics.

AgeCurve founder Attila Csordas' presentation at Undoing Aging 2018 explained how their direct-to-consumer proteomics platform can help clients to understand their personal aging process at the molecular level, as well as the impact of novel therapies.

A new article in luxury industry magazine Luxe Digital profiles SENS Research Foundation and discusses the potential for rejuvenation biotechnology to comprehensively repair the damage caused by aging, thus preventing the diseases of old age.

Dr. Brian Kennedy's presentation at Undoing Aging 2018 looked back over the history of research into healthy life extension in animals and humans, before introducing Singapore's current efforts to become a global leader in the field.

The Longevity Industry Landscape Overview 2018 is a 650 page analytical report which charts the markets, trends and sectors of the emerging healthy life extension industry, including profiles of major companies and investors.

Co-authored by futurists José Luis Cordeiro and David Wood, and with a foreword by Dr. de Grey, La Muerte de la Muerte (in Spanish) emphasises the feasibility and moral urgency of defeating age-related disease - with proceeds being donated to SRF. Also available on Amazon!

San Francisco Chronicle Editor in Chief Audrey Cooper moderates a lively discussion between SRF CSO Aubrey de Grey and William Hurlburt, Adjunct Professor at the Stanford Medical School, centered around the medical potential and ethical implications of living forever.

Our new Annual Report, covering accomplishments in 2017 and over the first part of this year, has now been released!  It's packed with information on our research projects, education programs, and outreach activities.

In cooperation with the Forever Healthy Foundation, SRF is inviting candidates to submit research proposals for a three-year Fellowship in Rejuvenation Biotechnology at our Research Center in California. The deadline for initial applications is August 6th 2018.

We're seeking a full-time researcher for a Scientist I position at our Research Center in California, to lead a new intramural research project performing translational research studying aging as it relates to the immune system.